112 related articles for article (PubMed ID: 10576449)
1. Amyloid beta-peptide inhibits Na+-dependent glutamate uptake.
Lauderback CM; Harris-White ME; Wang Y; Pedigo NW; Carney JM; Butterfield DA
Life Sci; 1999; 65(18-19):1977-81. PubMed ID: 10576449
[TBL] [Abstract][Full Text] [Related]
2. Amyloid beta peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures.
Harris ME; Wang Y; Pedigo NW; Hensley K; Butterfield DA; Carney JM
J Neurochem; 1996 Jul; 67(1):277-86. PubMed ID: 8667003
[TBL] [Abstract][Full Text] [Related]
3. beta-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease.
Harris ME; Carney JM; Cole PS; Hensley K; Howard BJ; Martin L; Bummer P; Wang Y; Pedigo NW; Butterfield DA
Neuroreport; 1995 Oct; 6(14):1875-9. PubMed ID: 8547588
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory effects of beta-amyloid on glutamate and glucose uptakes by cultured astrocytes.
Parpura-Gill A; Beitz D; Uemura E
Brain Res; 1997 Apr; 754(1-2):65-71. PubMed ID: 9134960
[TBL] [Abstract][Full Text] [Related]
5. Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades.
Matos M; Augusto E; Oliveira CR; Agostinho P
Neuroscience; 2008 Oct; 156(4):898-910. PubMed ID: 18790019
[TBL] [Abstract][Full Text] [Related]
6. Na+ and K+ ion imbalances in Alzheimer's disease.
Vitvitsky VM; Garg SK; Keep RF; Albin RL; Banerjee R
Biochim Biophys Acta; 2012 Nov; 1822(11):1671-81. PubMed ID: 22820549
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids prevent the amyloid β-induced activation of astroglial hemichannels: A neuroprotective mechanism.
Gajardo-Gómez R; Labra VC; Maturana CJ; Shoji KF; Santibañez CA; Sáez JC; Giaume C; Orellana JA
Glia; 2017 Jan; 65(1):122-137. PubMed ID: 27757991
[TBL] [Abstract][Full Text] [Related]
8. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42.
Lauderback CM; Hackett JM; Huang FF; Keller JN; Szweda LI; Markesbery WR; Butterfield DA
J Neurochem; 2001 Jul; 78(2):413-6. PubMed ID: 11461977
[TBL] [Abstract][Full Text] [Related]
9. Beta-amyloid prevents excitotoxicity via recruitment of glial glutamate transporters.
Baba A; Mitsumori K; Yamada MK; Nishiyama N; Matsuki N; Ikegaya Y
Naunyn Schmiedebergs Arch Pharmacol; 2003 Sep; 368(3):234-8. PubMed ID: 14513203
[TBL] [Abstract][Full Text] [Related]
10. ß-amyloid-related peptides potentiate K+-evoked glutamate release from adult rat hippocampal slices.
Kabogo D; Rauw G; Amritraj A; Baker G; Kar S
Neurobiol Aging; 2010 Jul; 31(7):1164-72. PubMed ID: 18819729
[TBL] [Abstract][Full Text] [Related]
11. Astrocytic adenosine A2A receptors control the amyloid-β peptide-induced decrease of glutamate uptake.
Matos M; Augusto E; Machado NJ; dos Santos-Rodrigues A; Cunha RA; Agostinho P
J Alzheimers Dis; 2012; 31(3):555-67. PubMed ID: 22647260
[TBL] [Abstract][Full Text] [Related]
12. Insulin Attenuates Beta-Amyloid-Associated Insulin/Akt/EAAT Signaling Perturbations in Human Astrocytes.
Han X; Yang L; Du H; Sun Q; Wang X; Cong L; Liu X; Yin L; Li S; Du Y
Cell Mol Neurobiol; 2016 Aug; 36(6):851-864. PubMed ID: 26358886
[TBL] [Abstract][Full Text] [Related]
13. Neurodegeneration mediated by glutamate and beta-amyloid peptide: a comparison and possible interaction.
Gray CW; Patel AJ
Brain Res; 1995 Sep; 691(1-2):169-79. PubMed ID: 8590049
[TBL] [Abstract][Full Text] [Related]
14. Alteration of global protein SUMOylation in neurons and astrocytes in response to Alzheimer's disease-associated insults.
Maruyama T; Wada H; Abe Y; Niikura T
Biochem Biophys Res Commun; 2018 Jun; 500(2):470-475. PubMed ID: 29660340
[TBL] [Abstract][Full Text] [Related]
15. Astroglial Connexins as a Therapeutic Target for Alzheimer's Disease.
Yi C; Koulakoff A; Giaume C
Curr Pharm Des; 2017; 23(33):4958-4968. PubMed ID: 28982320
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of dietary restriction on cerebral cortical synaptic terminals: preservation of glucose and glutamate transport and mitochondrial function after exposure to amyloid beta-peptide, iron, and 3-nitropropionic acid.
Guo Z; Ersoz A; Butterfield DA; Mattson MP
J Neurochem; 2000 Jul; 75(1):314-20. PubMed ID: 10854276
[TBL] [Abstract][Full Text] [Related]
17. Ca(2+) -dependent endoplasmic reticulum stress correlates with astrogliosis in oligomeric amyloid β-treated astrocytes and in a model of Alzheimer's disease.
Alberdi E; Wyssenbach A; Alberdi M; Sánchez-Gómez MV; Cavaliere F; Rodríguez JJ; Verkhratsky A; Matute C
Aging Cell; 2013 Apr; 12(2):292-302. PubMed ID: 23409977
[TBL] [Abstract][Full Text] [Related]
18. Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer's disease patients.
Liang Z; Valla J; Sefidvash-Hockley S; Rogers J; Li R
J Neurochem; 2002 Mar; 80(5):807-14. PubMed ID: 11948244
[TBL] [Abstract][Full Text] [Related]
19. Reactive astrocytes give neurons less support: implications for Alzheimer's disease.
Steele ML; Robinson SR
Neurobiol Aging; 2012 Feb; 33(2):423.e1-13. PubMed ID: 21051108
[TBL] [Abstract][Full Text] [Related]
20. Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease.
Zumkehr J; Rodriguez-Ortiz CJ; Cheng D; Kieu Z; Wai T; Hawkins C; Kilian J; Lim SL; Medeiros R; Kitazawa M
Neurobiol Aging; 2015 Jul; 36(7):2260-2271. PubMed ID: 25964214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
